Markets
Goldman
@goldman_...
Bought ALNY
Shares
down -2.13%
At 275.0, Exited 269.1
Investing in ALNY seems promising due to its successful phase III study for Anvuttra in treating ATTR amyloidosis with cardiomyopathy, coupled with be...
Read
More
Thesis
Investing in ALNY seems promising due to its successful phase III study for Anvuttra in treating ATTR amyloidosis with cardiomyopathy, coupled with better-than-expected Q1 earnings and revenue. The strong drug pipeline and market momentum indicate potential further upside.
Go back
Tudor
@tudor-in...
Bought ALNY
Shares
up 12.6%
At 243.3, Now 270.0
Trims & Adds
[] Currently up $1.9M
[-] 229d ago
Trimmed 47.8K shares @
275.03
[+] 321d ago
Initial 60.4K shares @
243.30
Thesis
Go back
Two
@two-sigm...
Bought ALNY
Shares
up 53.85%
At 153.3, Now 270.0
Trims & Adds
[] Currently up $24.7M
[-] 229d ago
Trimmed 155.6K shares @
275.03
[-] 1.1y ago
Trimmed 300.00 shares @
153.33
[+] 321d ago
Added 69.1K shares @
243.32
[+] 1.1y ago
Initial 189.6K shares @
153.30
Thesis
Go back
Josh
@josh-got...
Bought ALNY
Shares
down -7.92%
At 195.1, Exited 179.6
Thesis
Go back
Point72
@point72-...
Bought ALNY
Shares
up 42.38%
At 194.9, Exited 243.0
Trims & Adds
[] Made $14.9M in profit
[-] 321d ago
All out @
243.00
[+] 1.1y ago
Added 120.3K shares @
153.33
[+] 1.4y ago
Initial 86.0K shares @
194.90
Thesis
Go back
Pinebridge
@pinebrid...
Bought ALNY
Shares
up 48.31%
At 179.0, Now 270.0
Trims & Adds
[] Currently up $1.1M
[-] 229d ago
Trimmed 688.00 shares @
275.03
[-] 321d ago
Trimmed 4.4K shares @
243.32
[+] 1.1y ago
Added 3.2K shares @
153.33
[+] 1.4y ago
Added 2.8K shares @
194.93
[+] 1.6y ago
Initial 7.4K shares @
179.00
Thesis
Go back
Two
@two-sigm...
Bought ALNY
Shares
up 34.87%
At 200.2, Now 270.0
Thesis
Go back
Duquesne
@duquesne...
Bought ALNY
Shares
down -2.52%
At 200.2, Exited 195.1
Thesis
Go back
